TrialCardiovascular drugs and therapy2025

Comparative analysis of the addition of empagliflozin versus doubling the furosemide dose in decompensated heart failure.

Fuat Polat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.